GENE ONLINE|News &
Opinion
Blog

2018-05-22|

May 22, 1989: NCI’s First Attempt to Genetically Engineer and Modify the Ability of Human Lymphocyte

by GeneOnline
Share To

On May 22, 1989, Dr. Steven A. Rosenberg, a scientist at the National Cancer Institute (NCI), performed the first human gene transfer trial in the history. Dr. Rosenberg implanted the human tumor-infiltrating lymphocytes with a foreign bacterial gene added to human body, and attempted to use genetic engineering to enhance the tracking and cytophagic abilities of lymphocytes.

Reference
https://www.nih.gov/about-nih/what-we-do/nih-almanac/national-cancer-institute-nci

©www.geneonline.com All rights reserved. Collaborate with us: service@geneonlineasia.com
Related Post
R&D
UT Southwestern Study Unveils Acidic Defense Mechanism of Cancer Cells
2024-04-09
R&D
Efficient Phage Production System Promises Win Against Superbugs
2022-07-20
AbbVie’s Big Moves; Expanding with One Company, Cutting Ties with Another
2022-04-21
LATEST
ImmunityBio’s ANKTIVA® Granted FDA Approval: Breakthrough IL-15 Receptor Agonist First-in-Class for BCG-Unresponsive Non-Muscle Invasive Bladder Cancer
2024-04-24
Takeda, Astellas, and Sumitomo Mitsui Banking Declare Agreement For Early Drug Discovery Program Incubation in Joint Venture
2024-04-23
Ochre Bio Announces Partnership with Boehringer Ingelheim to Develop Novel Regenerative Treatments for Patients with Advanced Liver Disease
2024-04-22
Earth Day Awareness: Hospitals Embrace Sustainability Efforts
2024-04-22
WHO Raises Alarm: Bird Flu Threat to Humans an ‘Enormous Concern’
2024-04-19
The Legal Battlefield of Weight-Loss Drugs: Eli Lilly and Novo Nordisk on the Defensive
2024-04-18
Pharmacogenomics in Asia-Pacific: Nalagenetics CEO Levana Sani Offers Insights and Strategies
2024-04-17
EVENT
2024-04-27
2024 Biomedical Final Pitch Competition
Room DA1620, Dana Building, Dana-Farber Cancer Institute, 99 Jimmy Fund Way, Boston, MA 02115
Scroll to Top